Japan Topical Scar Treatment Market Size, Share & Trends Analysis Report By End-use, By Scar Type (Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks), By Product, and Forecast, 2023 - 2030

The Japan Topical Scar Treatment Market size is expected to reach $1.5 Billion by 2030, rising at a market growth of 9.3% CAGR during the forecast period.

Japan's topical scar treatment market has witnessed significant growth in recent years. Japan, a highly developed nation with a large aging population, has a considerable industry for scar treatment products and services. The Japanese industry for topical scar treatment products comprises many options, including creams, gels, ointments, and silicone sheets. These products aim to improve the appearance of scars from surgeries, accidents, acne, or other injuries. Consumers in Japan are increasingly seeking effective and non-invasive solutions to address their scar concerns, leading to a surge in the demand for topical treatments.

Furthermore, skincare brands in Japan are investing heavily in research and development to create innovative scar treatment formulations. These formulations often incorporate advanced ingredients such as retinoids, vitamin C, niacinamide, and hyaluronic acid, known for their ability to promote collagen production, fade hyperpigmentation, and improve overall skin texture.

The COVID-19 pandemic has impacted Japan's healthcare and beauty sectors, including the topical scar treatment market. During the initial phases of the pandemic, there was a significant disruption in healthcare services, with elective procedures and non-urgent dermatological consultations being postponed or canceled. This led to a temporary decline in the demand for scar treatment products and services as consumers prioritized essential healthcare needs and adhered to stay-at-home measures.

Furthermore, the pandemic accelerated the adoption of telemedicine and e-commerce platforms for skincare consultations and product purchases. Many dermatologists and skincare experts in Japan began offering virtual consultations and recommending topical scar treatment products online, contributing to the growth of the digital scar treatment industry. According to the International Trade Administration, Japan's telemedicine industry will grow from USD 243 million in 2020 to USD 404.5 million by 2025. As telemedicine continues to reshape the landscape of healthcare delivery, it opens up opportunities for specialized fields like the topical scar treatment market in Japan to integrate these advancements, potentially leading to more effective and convenient solutions for patients seeking scar management and dermatological care.

Market Trends

Growing emphasis on skincare and beauty

In recent years, there has been a notable shift in Japanese consumer preferences towards scar treatment products that address the physical aspects of scarring and cater to the desire for flawless skin and improved aesthetics. One key aspect driving this emphasis on skincare and beauty in the topical scar treatment market is the Japanese concept of "bihaku" or "beautiful white." In Japan, there is a cultural preference for clear, radiant, and evenly toned skin, which has led to a proliferation of scar treatment products that reduce the visibility of scars and promote overall skin health and radiance.

Another factor driving the emphasis on skincare and beauty in the topical scar treatment market is the growing awareness of the importance of self-care and self-expression. As the Japanese become more conscious of their appearance and seek ways to enhance their confidence, there is a greater demand for scar treatment products that deliver results and provide a luxurious and indulgent skincare experience.

According to the International Trade Administration, in 2019, Japan's cosmetics and personal care products industry reached a substantial industry size of approximately USD 35 billion. As this trend extends to the topical scar treatment market in Japan, there is a growing focus on enhancing skincare routines and addressing beauty concerns, further driving innovation and demand in the industry.

Furthermore, Japanese consumers increasingly seek multifunctional skincare solutions that offer benefits beyond scar treatment alone. Products that combine scar-reducing ingredients with moisturizers, antioxidants, and UV protection have gained popularity as they address multiple skin concerns and contribute to a holistic approach to skincare. Thus, Japan's shift towards scar treatment products reflects cultural ideals of beauty and a growing demand for holistic skincare solutions.

Increasing prevalence of keloid scars

In recent years, Japan has witnessed a notable surge in the prevalence of keloid scars within the topical scar treatment market. While keloids emerge from various forms of trauma, including surgery, burns, or even minor cuts, their tendency to increase beyond the boundaries of the original wound presents a significant challenge in scar management. The rising prevalence of keloid scars in Japan has prompted a surge in research and innovation within the topical scar treatment market.

In response to the growing demand for more productive and less invasive solutions, the Japanese industry has witnessed the emergence of novel topical treatments targeting keloid scars. These innovative formulations leverage advancements in biomedical research, including incorporating growth factors, cytokines, and other bioactive compounds to modulate the wound healing process and mitigate aberrant scar formation.

Furthermore, advancements in nanotechnology have facilitated the development of targeted drug delivery systems, enabling precise and sustained release of therapeutic agents to the scar site. Moreover, integrating digital health technologies, such as smartphone applications and wearable devices, has facilitated remote monitoring and personalized care for individuals undergoing scar treatment. Therefore, Japan's topical scar treatment market is witnessing a surge in innovation driven by advancements in biomedical research, nanotechnology, and digital health integration to address the rising prevalence of keloid scars.

Competition Analysis

The topical scar treatment market in Japan is characterized by various companies offering innovative solutions to address the needs of consumers seeking to minimize the appearance of scars. From established pharmaceutical firms to specialized skincare brands, these companies contribute to a diverse landscape of scar management products tailored to Japanese consumers' unique preferences and requirements.

One prominent player in the Japanese topical scar treatment market is Rohto Pharmaceutical Co., Ltd., a leading Japanese healthcare company renowned for its wide range of skincare and pharmaceutical products. Rohto offers scar treatment formulations under brands like Medicated Lip Stick and Hada Labo, leveraging ingredients such as hyaluronic acid and vitamin C to promote scar healing and improve skin texture. With a strong presence in both over-the-counter and prescription segments, Rohto remains a key contributor to scar management in Japan.

Similarly, Mandom Corporation, a Japanese personal care company, has become a significant player in the topical scar treatment market through brands like GATSBY and Lucido. Mandom's scar treatment products often feature botanical extracts and moisturizing agents to nourish the skin and reduce the visibility of scars. These products are widely available in drugstores and cosmetic retailers across Japan, catering to consumers seeking effective and affordable scar management solutions.

Another notable player in the Japanese industry is Kao Corporation, a multinational consumer goods company known for its skincare and beauty brands. Kao offers scar treatment products under the Bioré and Curel lines, leveraging its expertise in dermatological research to develop formulations suitable for sensitive skin. These products contain ingredients like ceramides and collagen to promote scar healing and restore skin barrier function, addressing consumers' concerns with various scar types.

In addition to established players, the Japanese topical scar treatment market sees participation from emerging companies specializing in advanced skincare technology. For example, Lion Corporation, a Japanese manufacturer of oral care and skin care products, has ventured into scar management with offerings like Lush Bloom and AQUA Moi. These products incorporate innovative ingredients such as arbutin and allantoin to fade scars and improve skin tone, appealing to consumers seeking cutting-edge solutions for scar treatment.

Furthermore, Japanese consumers access various imported scar treatment brands from international pharmaceutical and skincare companies. Brands like Mederma, manufactured by Merz Pharmaceuticals, LLC, and Stratpharma AG, a Swiss biotech company, have gained popularity in Japan for their efficacy in scar management. These imported products often undergo rigorous testing and regulatory approval to meet Japanese standards, ensuring their safety and effectiveness for the local industry. As the demand for scar treatment continues to grow in Japan, fueled by increased skincare awareness and a focus on aesthetic concerns, the topical scar treatment market is poised for further expansion and innovation.

List of Key Companies Profiled

• Smith & Nephew PLC
• Lumenis Be Ltd.
• Merz Pharma GmbH & Co. KGaA
• Sonoma Pharmaceuticals, Inc.
• Molnlycke Health Care AB
• Suneva Medical, Inc.
• Perrigo Company PLC
• Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
• Newmedical Technology Inc.
• Integra LifeSciences Holdings Corporation

Japan Topical Scar Treatment Market Report Segmentation

By End-use

• Hospitals
• Clinics
• Homecare

By Scar Type

• Atrophic Scars
• Hypertrophic & Keloid Scars
• Contracture Scars
• Stretch Marks

By Product

• Creams
• Gels
• Silicon Sheets
• Others

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Japan Topical Scar Treatment Market, by End-use
1.4.2 Japan Topical Scar Treatment Market, by Scar Type
1.4.3 Japan Topical Scar Treatment Market, by Product
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Opportunities
2.2.3 Market Restraints
2.2.4 Market Challenges
2.2.5 Market Trends
2.3 Porter’s Five Forces Analysis

Chapter 3. Japan Topical Scar Treatment Market
3.1 Japan Topical Scar Treatment Market by End-use
3.2 Japan Topical Scar Treatment Market by Scar Type
3.3 Japan Topical Scar Treatment Market by Product

Chapter 4. Company Profiles – Global Leaders
4.1 Smith & Nephew PLC
4.1.1 Company Overview
4.1.2 Financial Analysis
4.1.3 Regional and Segmental Analysis
4.1.4 Research & Development Expense
4.1.5 SWOT Analysis
4.2 Lumenis Be Ltd.
4.2.1 Company Overview
4.2.2 Recent strategies and developments:
4.2.2.1 Partnerships, Collaborations, and Agreements:
4.2.2.2 Product Launches and Product Expansions:
4.2.3 SWOT Analysis
4.3 Merz Pharma GmbH & Co. KGaA
4.3.1 Company Overview
4.3.2 Recent strategies and developments:
4.3.2.1 Partnerships, Collaborations, and Agreements:
4.3.3 SWOT Analysis
4.4 Sonoma Pharmaceuticals, Inc.
4.4.1 Company Overview
4.4.2 Financial Analysis
4.4.3 Regional Analysis
4.4.4 Research & Development Expenses
4.4.5 Recent strategies and developments:
4.4.5.1 Product Launches and Product Expansions:
4.4.6 SWOT Analysis
4.5 Molnlycke Health Care AB
4.5.1 Company Overview
4.5.2 SWOT Analysis
4.6 Suneva Medical, Inc.
4.6.1 Company Overview
4.6.2 Recent strategies and developments:
4.6.2.1 Product Launches and Product Expansions:
4.6.3 SWOT Analysis
4.7 Perrigo Company PLC
4.7.1 Company Overview
4.7.2 Financial Analysis
4.7.3 Segmental and Regional Analysis
4.7.4 Research & Development Expenses
4.7.5 SWOT Analysis
4.8 Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
4.8.1 Company Overview
4.8.2 Recent strategies and developments:
4.8.2.1 Partnerships, Collaborations, and Agreements:
4.8.2.2 Product Launches and Product Expansions:
4.8.3 SWOT Analysis
4.9 Newmedical Technology Inc.
4.9.1 Company Overview
4.9.2 SWOT Analysis
4.10. Integra LifeSciences Holdings Corporation
4.10.1 Company Overview
4.10.2 Financial Analysis
4.10.3 Segmental and Regional Analysis
4.10.4 Research & Development Expenses
4.10.5 SWOT Analysis

TABLE 1 Japan Topical Scar Treatment Market, 2019 - 2022, USD Million
TABLE 2 Japan Topical Scar Treatment Market, 2023 - 2030, USD Million
TABLE 3 Japan Topical Scar Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 4 Japan Topical Scar Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 5 Japan Topical Scar Treatment Market by Scar Type, 2019 - 2022, USD Million
TABLE 6 Japan Topical Scar Treatment Market by Scar Type, 2023 - 2030, USD Million
TABLE 7 Japan Topical Scar Treatment Market by Product, 2019 - 2022, USD Million
TABLE 8 Japan Topical Scar Treatment Market by Product, 2023 - 2030, USD Million
TABLE 9 Key Information – Smith & Nephew PLC
TABLE 10 key Information – Lumenis Be Ltd.
TABLE 11 Key information – Merz Pharma GmbH & Co. KGaA
TABLE 12 Key Information – Sonoma Pharmaceuticals, Inc.
TABLE 13 Key Information – Molnlycke Health Care AB
TABLE 14 Key Information – Suneva Medical, Inc.
TABLE 15 Key Information – Perrigo Company PLC
TABLE 16 Key Information – Cynosure, LLC
TABLE 17 Key Information – Newmedical Technology Inc.
TABLE 18 Key Information – Integra LifeSciences Holdings Corporation

List of Figures
FIG 1 Methodology for the research
FIG 2 Japan Topical Scar Treatment Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Topical Scar Treatment Market
FIG 4 Porter’s Five Forces Analysis - Topical Scar Treatment Market
FIG 5 Japan Topical Scar Treatment Market share by End-use, 2022
FIG 6 Japan Topical Scar Treatment Market share by End-use, 2030
FIG 7 Japan Topical Scar Treatment Market by End-use, 2019 - 2030, USD Million
FIG 8 Japan Topical Scar Treatment Market share by Scar Type, 2022
FIG 9 Japan Topical Scar Treatment Market share by Scar Type, 2030
FIG 10 Japan Topical Scar Treatment Market by Scar Type, 2019 - 2030, USD Million
FIG 11 Japan Topical Scar Treatment Market share by Product, 2022
FIG 12 Japan Topical Scar Treatment Market share by Product, 2030
FIG 13 Japan Topical Scar Treatment Market by Product, 2019 - 2030, USD Million
FIG 14 SWOT Analysis: Smith & Nephew PLC
FIG 15 SWOT Analysis: Lumenis Be Ltd
FIG 16 SWOT Analysis: Merz Pharma GmbH & Co. KGaA
FIG 17 SWOT Analysis: Sonoma Pharmaceuticals, Inc.
FIG 18 Swot Analysis: Molnlycke Health Care AB
FIG 19 Swot Analysis: Suneva Medical, Inc.
FIG 20 SWOT Analysis: Perrigo Company PLC
FIG 21 Swot Analysis: CYNOSURE, LLC
FIG 22 Swot Analysis: Newmedical Technology Inc.
FIG 23 SWOT Analysis: Integra LifeSciences Holdings Corporation